RxDoctor Payments Data

Anuj Garg, MD

Clinical Cardiac Electrophysiology · Urbana, ILNPI 1679585905

Payments from drug & device makers

$43,394in general payments, 2019–2025

Across 88 payments — averaging $493.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$19K
  • Cook Research Incorporated$18K
  • Cook Medical LLC$4K
  • Medtronic$1K
  • Biosense Webster, Inc.$1K
  • Cardiva Medical, Inc.$239
  • plus $193 from 4 others
$15,192in research payments, 2019–2025

Across 7 payments — averaging $2170.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cook Research Incorporated$15K

What the payments were for

  • Consulting fees$4,20016%
  • Speaking & faculty fees$13,88054%
  • Travel & lodging$4,37317%
  • Food & beverage$3,11612%
  • Education$100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,394 in reported general payments places this provider in the 55th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

See all clinical cardiac electrophysiology providers in Illinois

Medicare billing

Part B allowed, 2024
$141,123
Medicare patients
1,444
Services billed
2,393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban268$341,602
XareltoRivaroxaban88$117,868
Dofetilide67$21,757
Flecainide Acetate191$10,953
Propafenone Hcl ErPropafenone Hcl20$4,086
SotalolSotalol Hcl119$2,045
Metoprolol Succinate73$1,350
Amiodarone Hcl49$810
Diltiazem 24hr Er (Cd)Diltiazem Hcl27$530
Metoprolol Tartrate105$523
Lisinopril23$274
Carvedilol12$151

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$120$117,86888 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

Other clinical cardiac electrophysiology in Urbana

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →